| ■ 영문 제목 : Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Growth (Status and Outlook) 2021-2026 | |
 | ■ 상품코드 : LPI-2201K00119 ■ 조사/발행회사 : LP Information ■ 발행일 : 2021년 12월 (※2025년 최신판이 있습니다. 문의 주세요.) ■ 페이지수 : 87 ■ 작성언어 : 영어 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 ■ 조사대상 지역 : 글로벌 ■ 산업 분야 : 의료, 제약 |
| Single User (1명 열람용) | USD3,660 ⇒환산￦4,941,000 | 견적의뢰/주문/질문 |
| Multi User (5명 열람용) | USD5,490 ⇒환산￦7,411,500 | 견적의뢰/주문/질문 |
| Corporate User (동일기업내 공유가능) | USD7,320 ⇒환산￦9,882,000 | 견적의뢰/구입/질문 |
|
※가격옵션 설명 - 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다. - 지불방법은 계좌이체/무통장입금 또는 카드결제입니다. |
| 본 조사보고서는 혈우병 A 및 B 재조합 인자 대체 요법의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아, 중동/아프리카, 이집트, 남아프리카, 터키, 중동GCC국 등), 시장동향, 판매/유통업자/고객 리스트, 시장예측 (2021년-2026년), 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) 등의 정보를 포함하고 있습니다. 또한, 주요지역의 종류별 시장규모 (혈우병 A, 혈우병 B)와 용도별 시장규모 (병원, 클리닉, 외래 외과 센터) 데이터도 수록되어 있습니다. - 조사 범위 - 경영자용 요약 - 기업별 혈우병 A 및 B 재조합 인자 대체 요법 시장 점유율 - 지역별 혈우병 A 및 B 재조합 인자 대체 요법 시장규모 - 주요지역의 종류별 시장규모 (혈우병 A, 혈우병 B) - 주요지역의 용도별 시장규모 (병원, 클리닉, 외래 외과 센터) - 미주의 혈우병 A 및 B 재조합 인자 대체 요법 시장규모 (미국, 캐나다, 멕시코, 브라질 등) - 아시아의 혈우병 A 및 B 재조합 인자 대체 요법 시장규모 (중국, 일본, 한국, 동남아시아, 인도 등) - 유럽의 혈우병 A 및 B 재조합 인자 대체 요법 시장규모 (독일, 프랑스, 영국, 이탈리아, 러시아 등) - 중동/아프리카의 혈우병 A 및 B 재조합 인자 대체 요법 시장규모 (이집트, 남아프리카, 터키, 중동GCC지역 등) - 시장의 성장요인, 과제, 동향 - 마케팅, 유통업자, 고객리스트 - 세계의 혈우병 A 및 B 재조합 인자 대체 요법 시장예측 (2021년-2026년) - 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) Pfizer, Novo Nordisk, Baxalta, Bayer, Biogen, CSL Behring, Emergent Biosolutions, Spark therapeutics, Uniqure - 조사의 결과/결론 |
According to this latest study, the 2021 growth of Hemophilia A and B Recombinant Factor Replacement Therapy will have significant change from previous year. By the most conservative estimates of global Hemophilia A and B Recombinant Factor Replacement Therapy market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Hemophilia A and B Recombinant Factor Replacement Therapy market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.
This report presents a comprehensive overview, market shares, and growth opportunities of Hemophilia A and B Recombinant Factor Replacement Therapy market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.
Haemophilia A
Haemophilia B
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.
Hospitals
Clinics
Ambulatory Surgical Centers
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Pfizer
Novo Nordisk
Baxalta
Bayer
Biogen
CSL Behring
Emergent Biosolutions
Spark therapeutics
Uniqure
1 Scope of the Report 2 Executive Summary 3 Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Players 4 Hemophilia A and B Recombinant Factor Replacement Therapy by Regions 5 Americas 6 APAC 7 Europe 8 Middle East & Africa 9 Market Drivers, Challenges and Trends 10 Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Forecast 11 Key Players Analysis 12 Research Findings and Conclusion List of TablesTable 1. Hemophilia A and B Recombinant Factor Replacement Therapy Market Size CAGR by Region (2020-2026) & ($ Millions) Table 2. Major Players of Haemophilia A Table 3. Major Players of Haemophilia B Table 4. Hemophilia A and B Recombinant Factor Replacement Therapy Market Size CAGR by Type (2020-2026) & ($ Millions) Table 5. Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Type (2016-2021) & ($ Millions) Table 6. Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Size Market Share by Type (2016-2021) Table 7. Hemophilia A and B Recombinant Factor Replacement Therapy Market Size CAGR by Application (2016-2021) & ($ Millions) Table 8. Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Application (2016-2021) & ($ Millions) Table 9. Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Size Market Share by Application (2016-2021) Table 10. Global Hemophilia A and B Recombinant Factor Replacement Therapy Revenue by Players (2019-2021E) & ($ Millions) Table 11. Global Hemophilia A and B Recombinant Factor Replacement Therapy Revenue Market Share by Players (2019-2021E) Table 12. Hemophilia A and B Recombinant Factor Replacement Therapy Key Players Head office and Products Offered Table 13. Hemophilia A and B Recombinant Factor Replacement Therapy Concentration Ratio (CR3, CR5 and CR10) & (2019-2021E) Table 14. New Products and Potential Entrants Table 15. Mergers & Acquisitions, Expansion Table 16. Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Regions 2016-2021 & ($ Millions) Table 17. Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Size Market Share by Regions 2016-2021 Table 18. Americas Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Country (2016-2021) & ($ Millions) Table 19. Americas Hemophilia A and B Recombinant Factor Replacement Therapy Market Size Market Share by Country (2016-2021) Table 20. Americas Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Type (2016-2021) & ($ Millions) Table 21. Americas Hemophilia A and B Recombinant Factor Replacement Therapy Market Size Market Share by Type (2016-2021) Table 22. Americas Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Application (2016-2021) & ($ Millions) Table 23. Americas Hemophilia A and B Recombinant Factor Replacement Therapy Market Size Market Share by Application (2016-2021) Table 24. APAC Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Region (2016-2021) & ($ Millions) Table 25. APAC Hemophilia A and B Recombinant Factor Replacement Therapy Market Size Market Share by Region (2016-2021) Table 26. APAC Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Type (2016-2021) & ($ Millions) Table 27. APAC Hemophilia A and B Recombinant Factor Replacement Therapy Market Size Market Share by Type (2016-2021) Table 28. APAC Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Application (2016-2021) & ($ Millions) Table 29. APAC Hemophilia A and B Recombinant Factor Replacement Therapy Market Size Market Share by Application (2016-2021) Table 30. Europe Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Country (2016-2021) & ($ Millions) Table 31. Europe Hemophilia A and B Recombinant Factor Replacement Therapy Market Size Market Share by Country (2016-2021) Table 32. Europe Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Type (2016-2021) & ($ Millions) Table 33. Europe Hemophilia A and B Recombinant Factor Replacement Therapy Market Size Market Share by Type (2016-2021) Table 34. Europe Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Application (2016-2021) & ($ Millions) Table 35. Europe Hemophilia A and B Recombinant Factor Replacement Therapy Market Size Market Share by Application (2016-2021) Table 36. Middle East & Africa Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Region (2016-2021) & ($ Millions) Table 37. Middle East & Africa Hemophilia A and B Recombinant Factor Replacement Therapy Market Size Market Share by Region (2016-2021) Table 38. Middle East & Africa Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Type (2016-2021) & ($ Millions) Table 39. Middle East & Africa Hemophilia A and B Recombinant Factor Replacement Therapy Market Size Market Share by Type (2016-2021) Table 40. Middle East & Africa Hemophilia A and B Recombinant Factor Replacement Therapy Market Size by Application (2016-2021) & ($ Millions) Table 41. Middle East & Africa Hemophilia A and B Recombinant Factor Replacement Therapy Market Size Market Share by Application (2016-2021) Table 42. Key and Potential Regions of Hemophilia A and B Recombinant Factor Replacement Therapy Table 43. Key Application and Potential Industries of Hemophilia A and B Recombinant Factor Replacement Therapy Table 44. Key Challenges of Hemophilia A and B Recombinant Factor Replacement Therapy Table 45. Key Trends of Hemophilia A and B Recombinant Factor Replacement Therapy Table 46. Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Size Forecast by Regions (2021-2026) & ($ Millions) Table 47. Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Size Market Share Forecast by Regions (2021-2026) Table 48. Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Size Forecast by Type (2021-2026) & ($ Millions) Table 49. Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Size Market Share Forecast by Type (2021-2026) Table 50. Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Size Forecast by Application (2021-2026) & ($ Millions) Table 51. Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Size Market Share Forecast by Application (2021-2026) Table 52. Pfizer Details, Company Type, Hemophilia A and B Recombinant Factor Replacement Therapy Area Served and Its Competitors Table 53. Pfizer Hemophilia A and B Recombinant Factor Replacement Therapy Product Offered Table 54. Pfizer Hemophilia A and B Recombinant Factor Replacement Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 55. Pfizer Main Business Table 56. Pfizer Latest Developments Table 57. Novo Nordisk Details, Company Type, Hemophilia A and B Recombinant Factor Replacement Therapy Area Served and Its Competitors Table 58. Novo Nordisk Hemophilia A and B Recombinant Factor Replacement Therapy Product Offered Table 59. Novo Nordisk Main Business Table 60. Novo Nordisk Hemophilia A and B Recombinant Factor Replacement Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 61. Novo Nordisk Latest Developments Table 62. Baxalta Details, Company Type, Hemophilia A and B Recombinant Factor Replacement Therapy Area Served and Its Competitors Table 63. Baxalta Hemophilia A and B Recombinant Factor Replacement Therapy Product Offered Table 64. Baxalta Main Business Table 65. Baxalta Hemophilia A and B Recombinant Factor Replacement Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 66. Baxalta Latest Developments Table 67. Bayer Details, Company Type, Hemophilia A and B Recombinant Factor Replacement Therapy Area Served and Its Competitors Table 68. Bayer Hemophilia A and B Recombinant Factor Replacement Therapy Product Offered Table 69. Bayer Main Business Table 70. Bayer Hemophilia A and B Recombinant Factor Replacement Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 71. Bayer Latest Developments Table 72. Biogen Details, Company Type, Hemophilia A and B Recombinant Factor Replacement Therapy Area Served and Its Competitors Table 73. Biogen Hemophilia A and B Recombinant Factor Replacement Therapy Product Offered Table 74. Biogen Main Business Table 75. Biogen Hemophilia A and B Recombinant Factor Replacement Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 76. Biogen Latest Developments Table 77. CSL Behring Details, Company Type, Hemophilia A and B Recombinant Factor Replacement Therapy Area Served and Its Competitors Table 78. CSL Behring Hemophilia A and B Recombinant Factor Replacement Therapy Product Offered Table 79. CSL Behring Main Business Table 80. CSL Behring Hemophilia A and B Recombinant Factor Replacement Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 81. CSL Behring Latest Developments Table 82. Emergent Biosolutions Details, Company Type, Hemophilia A and B Recombinant Factor Replacement Therapy Area Served and Its Competitors Table 83. Emergent Biosolutions Hemophilia A and B Recombinant Factor Replacement Therapy Product Offered Table 84. Emergent Biosolutions Main Business Table 85. Emergent Biosolutions Hemophilia A and B Recombinant Factor Replacement Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 86. Emergent Biosolutions Latest Developments Table 87. Spark therapeutics Details, Company Type, Hemophilia A and B Recombinant Factor Replacement Therapy Area Served and Its Competitors Table 88. Spark therapeutics Hemophilia A and B Recombinant Factor Replacement Therapy Product Offered Table 89. Spark therapeutics Main Business Table 90. Spark therapeutics Hemophilia A and B Recombinant Factor Replacement Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 91. Spark therapeutics Latest Developments Table 92. Uniqure Details, Company Type, Hemophilia A and B Recombinant Factor Replacement Therapy Area Served and Its Competitors Table 93. Uniqure Hemophilia A and B Recombinant Factor Replacement Therapy Product Offered Table 94. Uniqure Main Business Table 95. Uniqure Hemophilia A and B Recombinant Factor Replacement Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 96. Uniqure Latest Developments List of Figures Figure 1. Hemophilia A and B Recombinant Factor Replacement Therapy Report Years Considered Figure 2. Research Objectives Figure 3. Research Methodology Figure 4. Research Process and Data Source Figure 5. Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Size Growth Rate 2016-2026 ($ Millions) Figure 6. Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Size Market Share by Type in 2020 Figure 7. Hemophilia A and B Recombinant Factor Replacement Therapy in Hospitals Figure 8. Global Hemophilia A and B Recombinant Factor Replacement Therapy Market: Hospitals (2016-2021) & ($ Millions) Figure 9. Hemophilia A and B Recombinant Factor Replacement Therapy in Clinics Figure 10. Global Hemophilia A and B Recombinant Factor Replacement Therapy Market: Clinics (2016-2021) & ($ Millions) Figure 11. Hemophilia A and B Recombinant Factor Replacement Therapy in Ambulatory Surgical Centers Figure 12. Global Hemophilia A and B Recombinant Factor Replacement Therapy Market: Ambulatory Surgical Centers (2016-2021) & ($ Millions) Figure 13. Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Size Market Share by Application in 2020 Figure 14. Global Hemophilia A and B Recombinant Factor Replacement Therapy Revenue Market Share by Player in 2020 Figure 15. Global Hemophilia A and B Recombinant Factor Replacement Therapy Market Size Market Share by Regions (2016-2021) Figure 16. Americas Hemophilia A and B Recombinant Factor Replacement Therapy Market Size 2016-2021 ($ Millions) Figure 17. APAC Hemophilia A and B Recombinant Factor Replacement Therapy Market Size 2016-2021 ($ Millions) Figure 18. Europe Hemophilia A and B Recombinant Factor Replacement Therapy Market Size 2016-2021 ($ Millions) Figure 19. Middle East & Africa Hemophilia A and B Recombinant Factor Replacement Therapy Market Size 2016-2021 ($ Millions) Figure 20. Americas Hemophilia A and B Recombinant Factor Replacement Therapy Market Size Market Share by Country in 2020 Figure 21. Americas Hemophilia A and B Recombinant Factor Replacement Therapy Market Size Market Share by Type in 2020 Figure 22. Americas Hemophilia A and B Recombinant Factor Replacement Therapy Market Size Market Share by Application in 2020 Figure 23. United States Hemophilia A and B Recombinant Factor Replacement Therapy Market Size Growth 2016-2021 ($ Millions) Figure 24. Canada Hemophilia A and B Recombinant Factor Replacement Therapy Market Size Growth 2016-2021 ($ Millions) Figure 25. Mexico Hemophilia A and B Recombinant Factor Replacement Therapy Market Size Growth 2016-2021 ($ Millions) Figure 26. APAC Hemophilia A and B Recombinant Factor Replacement Therapy Market Size Market Share by Regions in 2020 Figure 27. APAC Hemophilia A and B Recombinant Factor Replacement Therapy Market Size Market Share by Type in 2020 Figure 28. APAC Hemophilia A and B Recombinant Factor Replacement Therapy Market Size Market Share by Application in 2020 Figure 29. China Hemophilia A and B Recombinant Factor Replacement Therapy Market Size Growth 2016-2021 ($ Millions) Figure 30. Japan Hemophilia A and B Recombinant Factor Replacement Therapy Market Size Growth 2016-2021 ($ Millions) Figure 31. Korea Hemophilia A and B Recombinant Factor Replacement Therapy Market Size Growth 2016-2021 ($ Millions) Figure 32. Southeast Asia Hemophilia A and B Recombinant Factor Replacement Therapy Market Size Growth 2016-2021 ($ Millions) Figure 33. India Hemophilia A and B Recombinant Factor Replacement Therapy Market Size Growth 2016-2021 ($ Millions) Figure 34. Australia Hemophilia A and B Recombinant Factor Replacement Therapy Market Size Growth 2016-2021 ($ Millions) Figure 35. Europe Hemophilia A and B Recombinant Factor Replacement Therapy Market Size Market Share by Country in 2020 Figure 36. Europe Hemophilia A and B Recombinant Factor Replacement Therapy Market Size Market Share by Type in 2020 Figure 37. Europe Hemophilia A and B Recombinant Factor Replacement Therapy Market Size Market Share by Application in 2020 Figure 38. Germany Hemophilia A and B Recombinant Factor Replacement Therapy Market Size Growth 2016-2021 ($ Millions) Figure 39. France Hemophilia A and B Recombinant Factor Replacement Therapy Market Size Growth 2016-2021 ($ Millions) Figure 40. UK Hemophilia A and B Recombinant Factor Replacement Therapy Market Size Growth 2016-2021 ($ Millions) Figure 41. Italy Hemophilia A and B Recombinant Factor Replacement Therapy Market Size Growth 2016-2021 ($ Millions) Figure 42. Russia Hemophilia A and B Recombinant Factor Replacement Therapy Market Size Growth 2016-2021 ($ Millions) Figure 43. Middle East & Africa Hemophilia A and B Recombinant Factor Replacement Therapy Market Size Market Share by Region in 2020 Figure 44. Middle East & Africa Hemophilia A and B Recombinant Factor Replacement Therapy Market Size Market Share by Type in 2020 Figure 45. Middle East & Africa Hemophilia A and B Recombinant Factor Replacement Therapy Market Size Market Share by Application in 2020 Figure 46. Egypt Hemophilia A and B Recombinant Factor Replacement Therapy Market Size Growth 2016-2021 ($ Millions) Figure 47. South Africa Hemophilia A and B Recombinant Factor Replacement Therapy Market Size Growth 2016-2021 ($ Millions) Figure 48. Israel Hemophilia A and B Recombinant Factor Replacement Therapy Market Size Growth 2016-2021 ($ Millions) Figure 49. Turkey Hemophilia A and B Recombinant Factor Replacement Therapy Market Size Growth 2016-2021 ($ Millions) Figure 50. GCC Country Hemophilia A and B Recombinant Factor Replacement Therapy Market Size Growth 2016-2021 ($ Millions) Figure 51. Americas Hemophilia A and B Recombinant Factor Replacement Therapy Market Size 2021-2026 ($ Millions) Figure 52. APAC Hemophilia A and B Recombinant Factor Replacement Therapy Market Size 2021-2026 ($ Millions) Figure 53. Europe Hemophilia A and B Recombinant Factor Replacement Therapy Market Size 2021-2026 ($ Millions) Figure 54. Middle East & Africa Hemophilia A and B Recombinant Factor Replacement Therapy Market Size 2021-2026 ($ Millions) Figure 55. United States Hemophilia A and B Recombinant Factor Replacement Therapy Market Size 2021-2026 ($ Millions) Figure 56. Canada Hemophilia A and B Recombinant Factor Replacement Therapy Market Size 2021-2026 ($ Millions) Figure 57. Mexico Hemophilia A and B Recombinant Factor Replacement Therapy Market Size 2021-2026 ($ Millions) Figure 58. Brazil Hemophilia A and B Recombinant Factor Replacement Therapy Market Size 2021-2026 ($ Millions) Figure 59. China Hemophilia A and B Recombinant Factor Replacement Therapy Market Size 2021-2026 ($ Millions) Figure 60. Japan Hemophilia A and B Recombinant Factor Replacement Therapy Market Size 2021-2026 ($ Millions) Figure 61. Korea Hemophilia A and B Recombinant Factor Replacement Therapy Market Size 2021-2026 ($ Millions) Figure 62. Southeast Asia Hemophilia A and B Recombinant Factor Replacement Therapy Market Size 2021-2026 ($ Millions) Figure 63. India Hemophilia A and B Recombinant Factor Replacement Therapy Market Size 2021-2026 ($ Millions) Figure 64. Australia Hemophilia A and B Recombinant Factor Replacement Therapy Market Size 2021-2026 ($ Millions) Figure 65. Germany Hemophilia A and B Recombinant Factor Replacement Therapy Market Size 2021-2026 ($ Millions) Figure 66. France Hemophilia A and B Recombinant Factor Replacement Therapy Market Size 2021-2026 ($ Millions) Figure 67. UK Hemophilia A and B Recombinant Factor Replacement Therapy Market Size 2021-2026 ($ Millions) Figure 68. Italy Hemophilia A and B Recombinant Factor Replacement Therapy Market Size 2021-2026 ($ Millions) Figure 69. Russia Hemophilia A and B Recombinant Factor Replacement Therapy Market Size 2021-2026 ($ Millions) Figure 70. Spain Hemophilia A and B Recombinant Factor Replacement Therapy Market Size 2021-2026 ($ Millions) Figure 71. Egypt Hemophilia A and B Recombinant Factor Replacement Therapy Market Size 2021-2026 ($ Millions) Figure 72. South Africa Hemophilia A and B Recombinant Factor Replacement Therapy Market Size 2021-2026 ($ Millions) Figure 73. Israel Hemophilia A and B Recombinant Factor Replacement Therapy Market Size 2021-2026 ($ Millions) Figure 74. Turkey Hemophilia A and B Recombinant Factor Replacement Therapy Market Size 2021-2026 ($ Millions) Figure 75. GCC Country Hemophilia A and B Recombinant Factor Replacement Therapy Market Size 2021-2026 ($ Millions) |
| ※본 조사보고서 [세계의 혈우병 A 및 B 재조합 인자 대체 요법 시장예측 2021년-2026년] (코드 : LPI-2201K00119) 판매에 관한 면책사항을 반드시 확인하세요. |
| ※본 조사보고서 [세계의 혈우병 A 및 B 재조합 인자 대체 요법 시장예측 2021년-2026년] 에 대해서 E메일 문의는 여기를 클릭하세요. |